Rotary’s lifesaving bowel cancer awareness initiative will receive a boost this year with the introduction of Clinical Genomics’ faecal immunochemical tests (FITs) in Bowelscan and BowelCare kits across Australia for …

The National Heart Foundation of Australia says the fact that heart disease remains the country’s single leading killer following the release of the 2013 Cause of Death Data from the …

NPS MedicineWise has launched a new learning program and health professional tools on the use of proton pump inhibitors in the treatment of uncomplicated gastro-oesophageal reflux disease. The program focuses …

Latest figures from the Australian Bureau of Statistics show Australian pharmaceutical exports declined by 18% to $2.9 billion in 2014, compared to $3.6 billion in the year before. Since 2012, …

A new HIV medicine is now available on the PBS to add to the range of treatment options available for people living with HIV in Australia. From 1 April 2015, …

The presence of a community pharmacy on a local main shopping or high street has a significant positive effect on health in the area, a UK report has found. The …

Professional Pharmacists Australia has welcomed the Competition Policy Review’s recommendation to reconsider pharmacy location rules. Professional Pharmacists Australia CEO Chris Walton is urging the government to reconsider location rules as …

The PSA has disagreed with the Competition Policy Review’s recommendations to deregulate pharmacy, saying the current system does not require fixing. The current system of community pharmacy has been proven …

The Pharmacy Guild of Australia has slammed the Competition Policy Review’s recommendations to deregulate pharmacies. The current model of community pharmacy serves the nation extremely well, the Guild says in …

The Competition Policy Review has recommended the removal of current restrictions on pharmacy ownership and location. These rules are unnecessary for ensuring quality of advice and care for patients, and …

Globally, the vitamin supplements market is expected to grow at a calculated annual growth rate of approximately 6.8% between 2014 and 2020, rising from a market value of US$37.4 billion …

Amneal Pharmaceuticals and Actavis Australia, a subsidiary of Actavis plc today announced they have signed a binding letter of intent which provides that Amneal intends to acquire substantially all of …